Related Experiment Video
Updated: Aug 6, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Left bundle branch block as a risk factor for progression to heart failure
Faiez Zannad1, Etienne Huvelle, Kenneth Dickstein
1CIC-INSERM-CHU de Nancy, Hôpital Jeanne d'Arc, Dommartin-lès-Toul, BP 303 - 54201 Toul Cedex, France. f.zannad@chu-nancy.fr
Insights
Left bundle branch block (LBBB) is common in heart failure (HF) and may worsen cardiac function and remodeling. This review explores LBBB
Area of Science:
- Cardiology
- Electrophysiology
Background:
- Left bundle branch block (LBBB) prevalence increases with age and cardiovascular disease.
- LBBB affects approximately 25% of heart failure (HF) patients.
- The detrimental role of conduction disturbances in HF progression may be underestimated.
Purpose of the Study:
- To review literature on the causative role of LBBB in cardiac dysfunction and HF development.
- To examine the mechanism of intra-ventricular asynchrony in LBBB-induced cardiac deterioration.
- To discuss potential future therapies for LBBB.
Main Methods:
- Literature review of existing studies on LBBB and heart failure.
Main Results:
- LBBB-induced intra-ventricular asynchrony contributes to cardiac function deterioration.
- Conduction disturbances like LBBB are implicated in cardiac remodeling and HF progression.
- Evidence suggests LBBB may play a causative role in HF development.
Conclusions:
- LBBB, via intra-ventricular asynchrony, is a significant factor in cardiac deterioration and HF.
- Further research into LBBB's causative role is warranted.
- Potential therapeutic strategies for LBBB in HF patients should be explored.
Abstract:
The prevalence of conduction disturbances, particularly left bundle branch block (LBBB), is strongly correlated with age and with the presence of cardiovascular disease. LBBB has been reported to affect approximately 25% of the heart failure (HF) population and it is likely that the deleterious role of such conduction disorders in the progression to HF has been underestimated. The purpose of this article is to review the data from the literature indicating that LBBB may have a causative role, mediated through the resulting intra-ventricular asynchrony, in the deterioration of cardiac function and the development of cardiac remodelling and HF. It also aims to address the potential for future clinical therapies for this conduction disorder.
Related Concept Videos
Heart Failure Drugs: β-Blockers
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure II: Pathophysiology
Mitral Regurgitation I: Introduction
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Heart Failure V: Medical Management